Fundraising Fox
/People
Sign in

Markus Gemuend

Investor

Senior Advisor at Adjuvant Capital

London / Kigali

Find your path to Markus

182 people in our graph can introduce you to Markus.

Sign up to see every warm intro you have to Markus

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Markus. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

About

Markus Gemuend is a biopharmaceutical executive with over twenty years of experience developing vaccines and biologics from early development through global commercialization. He has held leadership roles across R&D, operations, and market introduction at both multinational pharmaceutical companies and global health organizations. As a Senior Advisor at Adjuvant Capital, he advises on industrialization strategies, technology transfer, and partnerships aimed at expanding access to health products.

Invests in

BiotechDigital HealthImpact & Social Good

Experience

  1. BAMCO AfricaCo-Founder and CEOcurrent2023 — present
  2. Maximize Meaningful Education(M2E) FoundationCo-Founder and Chairmancurrent2012 — presentMusanze, Rwanda and San Francisco, CA, USA
  3. MalaicaBoard Membercurrent2022 — presentNairobi, Kenya
  4. University of California, RiversideAdvisory Board Member - Transformative Leadership in Disruptive Timescurrent2023 — present
  5. GenentechExecutive Director2021 — 2022South San Francisco, California, United States
  6. RocheHead of French and Portuguese Speaking Countries in Sub-Saharan Africa2019 — 2021Abidjan, Côte d’Ivoire
  7. RocheHead of Sub Saharan Africa Sub-Region2016 — 2020Lagos, Nigeria
  8. RocheGlobal Head of Roche Pharma Procurement2010 — 2016San Francisco, CA, USA and Basel, Switzerland
  9. GENENTECH FOUNDATIONBoard Member2005 — 2016San Francisco, California, United States
  10. GenentechGlobal Head of Biologics Manufacturing Genentech/Roche2007 — 2010South San Francisco, California
  11. GenentechHead of Contract Manufacturing and Manufacturing Collaborations2004 — 2007South San Francisco, California
  12. LonzaCEO2002 — 2004Basel, Switzerland
  13. LonzaHead of Lonza Biologics2001 — 2004Portsmouth, NH
  14. LonzaBusiness Head Small Molecules NA1998 — 2001Fair Lawn, New Jersey
  15. LonzaLegal Counsel1988 — 1998Basel, Switzerland

Skills & more

Biotechnology8Cross-functional Team Leadership13Pharmaceutical Industry11Strategic Planning7Strategy6FDA1

From Markus's professional profile.

Colleagues at Adjuvant Capital

Abrar Haque
Associate at Adjuvant Capital
Alexandra (Sandra) Glucksmann
Advisory Partner at Adjuvant Capital
Christian Mandl
Senior Advisor at Adjuvant Capital
Curt LaBelle
Venture Partner at Adjuvant Capital
Evelyn Yanatos
Director of Finance and Compliance at Adjuvant Capital
Gerard Cunningham
Operating Partner at Adjuvant Capital
Giulia Balconi
Associate at Adjuvant Capital
Glenn Rockman
Co-Founder and Partner at Adjuvant Capital

Frequently asked questions

Who is Markus Gemuend?
Markus Gemuend is a biopharmaceutical executive with over twenty years of experience developing vaccines and biologics from early development through global commercialization. He has held leadership roles across R&D, operations, and market introduction at both multinational pharmaceutical companies and global health organizations. As a Senior Advisor at Adjuvant Capital, he advises on industrialization strategies, technology transfer, and partnerships aimed at expanding access to health products.
Where does Markus Gemuend work?
Markus Gemuend is Senior Advisor at Adjuvant Capital.
What does Markus Gemuend invest in?
Markus Gemuend invests in Biotech, Digital Health, Impact & Social Good.
Where did Markus Gemuend go to school?
Markus Gemuend studied at University of Basel (Law).

Same school

Shared employers